Oct 25, 2020 | COVID-19, Featured
On this episode of the podcast, Terry and Bob discuss the triumph of the forthcoming Covid-19 vaccines, which are on the cusp of development just nine months after the Covid-19 disease was sequenced. Unfortunately, they point out, the media is engaging in...
Oct 17, 2020 | COVID-19, Featured, Podcast
On this week’s episode of the podcast, Bob reprises his interview with Janet Woodcock, the director of the Center for Drug Evaluation and Research (CDER) at the FDA, about the hurdles to reshoring drug manufacturing to the U.S. Currently, roughly 80 percent of...
Oct 10, 2020 | COVID-19, Featured
On this episode of the podcast, Terry and Bob argue that every patient should get the same high-value care that President Trump received to successfully treat his Covid-19. Here’s the list of medications that Trump received: Remdesivir Regeneron monoclonal...
Oct 3, 2020 | Featured, Podcast
On this episode of the podcast, Terry and Bob discuss the perverse status quo in the American healthcare system where those with rare and chronic diseases subsidize the healthy through the prescription drug rebate system. Each year, drugmakers pay hundreds of billions...
Sep 26, 2020 | COVID-19, Featured
On this episode of the podcast, Terry and Bob lament the politicization of medicine. Rather than relying on science to guide decisions around potential Covid-19 vaccines, the media and interest groups foster politicization. Terry highlights how patients are always the...
Sep 19, 2020 | COVID-19, Featured
On this week’s episode, Terry and Bob give an update on the Covid-19 vaccine, drug pricing, and Operation Warp Speed with Robert Popovian. The release of the first vaccine is set to begin in November for the most vulnerable patients. The goal of Operation Warp...
